I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The efficacy and safety of adding anlotinib in gradual prog..:
Xiang, Hai
;
Danna, Ding
;
Xuefei, Chen
..
Anti-Cancer Drugs. , 2024
Link:
https://doi.org/10.1097/cad.0000000000001575
RT Journal T1
The efficacy and safety of adding anlotinib in gradual progression on third-generation EGFR-TKIs for EGFR-mutant advanced nonsmall cell lung cancer
UL https://suche.suub.uni-bremen.de/peid=cr-10.1097_cad.0000000000001575&Exemplar=1&LAN=DE A1 Xiang, Hai A1 Danna, Ding A1 Xuefei, Chen A1 Zhao, Jinkai A1 Jin, Guangjun PB Ovid Technologies (Wolters Kluwer Health) YR 2024 SN 0959-4973 JF Anti-Cancer Drugs LK http://dx.doi.org/https://doi.org/10.1097/cad.0000000000001575 DO https://doi.org/10.1097/cad.0000000000001575 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)